Prediction of recurrent heart failure hospitalizations and mortality using the echocardiographic Killip score

Author:

Granot YoavORCID,Meir Yuval,Perl Michal Laufer,Milwidsky Assi,Sadeh Ben,Sapir Orly Ran,Trabelsi Adva,Banai Shmuel,Toplisky Yan,Havakuk Ofer

Abstract

Abstract Aim Examine the performance of a simple echocardiographic "Killip score" (eKillip) in predicting heart failure (HF) hospitalizations and mortality after index event of decompensated HF hospitalization. Methods HF patients hospitalized at our facility between 03/2019–03/2021 who underwent an echocardiography during their index admission were included in this retrospective analysis. The cohort was divided into 4 classes of eKillip according to: stroke volume index (SVI) < 35ml/m2 > and E/E' ratio < 15 > . An eKillip Class I was defined as SVI ≥ 35ml/m2 and E/E' ≤ 15 and was used as reference. Results Included 751 patients, median age 78.1 (IQR 69.3–86) years, 59% men, left ventricular ejection fraction 45 (IQR 30–60)%, brain natriuretic peptide levels 634 (IQR 331–1222)pg/ml. Compared with eKillip Class I, a graded increase in the combined endpoint of 30-day mortality and rehospitalizations rates was noted: (Class II: HR 1.77, CI 0.95–3.33, p = 0.07; Class III: HR 1.94, CI 1.05–3.6, p = 0.034; Class IV: HR 2.9, CI 1.64–5.13, p < 0.001 respectively), which overall persisted after correction for clinical (Class II: HR 1.682, CI 0.9–3.15, p = 0.105; Class III: HR 2.104, CI 1.13–3.9, p = 0.019; Class IV: HR 2.74, CI 1.54–4.85, p = 0.001 respectively) or echocardiographic parameters (Class II: HR 1.92, CI 1.02–3.63, p = 0.045; Class III: HR 1.54, CI 0.81–2.95, p = 0.189; Class IV: HR 2.04, CI 1.1–3.76, p = 0.023 respectively). Specifically, the eKillip Class IV group comprised one-third of the patient population and persistently showed increased risk of 30-day HF hospitalizations or mortality following multivariate analysis. Conclusion A simple echocardiographic score can assist identifying high-risk decompensated HF patients for recurrent hospitalizations and mortality.

Funder

Tel Aviv University

Publisher

Springer Science and Business Media LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3